Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix (Q47610748)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

radiation therapy

0 references

phosphorylation

0 references

author name string

Christopher M Lee

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

Dennis C Shrieve

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

Karen A Zempolich

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

R Jeffrey Lee

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

Elizabeth Hammond

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

Diana L Handrahan

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

David K Gaffney

7

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

language of work or name

0 references

publication date

12 September 2005

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

Gynecologic Oncology

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

99

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

415-421

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Stress and radiation-induced activation of multiple intracellular signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Expression of epidermal growth factor receptor in carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Prognostic value of epidermal growth factor receptor expression in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.05.045

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.05.045

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/16157365

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47610748&oldid=2162382257"